Trial Profile
Effect of anagliptin on plasma glucagon levels determined by LC-MS/MS in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2020
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 26 Feb 2019 Status changed from active, no longer recruiting to completed.
- 08 Oct 2018 New trial record